AU1395399A - Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis - Google Patents
Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis Download PDFInfo
- Publication number
- AU1395399A AU1395399A AU13953/99A AU1395399A AU1395399A AU 1395399 A AU1395399 A AU 1395399A AU 13953/99 A AU13953/99 A AU 13953/99A AU 1395399 A AU1395399 A AU 1395399A AU 1395399 A AU1395399 A AU 1395399A
- Authority
- AU
- Australia
- Prior art keywords
- protein
- nucleic acid
- group
- seq
- chag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0053—Oxidoreductases (1.) acting on a heme group of donors (1.9)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Compression Or Coding Systems Of Tv Signals (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003203787A AU2003203787B2 (en) | 1997-11-10 | 2003-04-17 | Differentially Expressed Genes in Cardiac Hypertrophy and their uses in Treatment and Diagnosis |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6504897P | 1997-11-10 | 1997-11-10 | |
| US60065048 | 1997-11-10 | ||
| US09189618 | 1998-11-09 | ||
| US09/189,618 US6610480B1 (en) | 1997-11-10 | 1998-11-09 | Treatment and diagnosis of cardiac hypertrophy |
| PCT/US1998/023953 WO1999024571A2 (en) | 1997-11-10 | 1998-11-10 | Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003203787A Division AU2003203787B2 (en) | 1997-11-10 | 2003-04-17 | Differentially Expressed Genes in Cardiac Hypertrophy and their uses in Treatment and Diagnosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1395399A true AU1395399A (en) | 1999-05-31 |
Family
ID=26745148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU13953/99A Abandoned AU1395399A (en) | 1997-11-10 | 1998-11-10 | Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6610480B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1030916A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2002508923A (cg-RX-API-DMAC7.html) |
| AU (1) | AU1395399A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2309360A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999024571A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6875567B1 (en) | 1997-11-10 | 2005-04-05 | Genentech, Inc. | Method of detecting cardiac hypertrophy through probe hybridization and gene expression analysis |
| WO2001013900A2 (en) | 1999-08-24 | 2001-03-01 | Medicure International Inc. | Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| EP1311704A2 (en) * | 2000-05-30 | 2003-05-21 | Medigene AG | Novel target genes for diseases of the heart |
| DE10126371A1 (de) * | 2001-05-30 | 2003-02-27 | Medigene Ag | Verfahren zur Identifizierung von Substanzen gegen Herzmuskelzellen-Hypertrophie |
| WO2002103355A1 (fr) * | 2001-06-18 | 2002-12-27 | Takeda Chemical Industries, Ltd. | Agents prophylactiques/remedes pour maladies cardiaques |
| WO2003006687A2 (en) * | 2001-07-10 | 2003-01-23 | Medigene Ag | Novel target genes for diseases of the heart |
| ITMI20012205A1 (it) * | 2001-10-22 | 2003-04-22 | Nanorganics Llc | Metodo e mezzi per l'identificazione precoce di rischi di scompenso cardiaco |
| US7482132B2 (en) | 2001-12-13 | 2009-01-27 | Sanofi-Aventis Deutschland Gmbh | Method for determining the activity of ornithine decarboxylase and for identifying effectors of ornithine decarboxylase activity |
| DE10161412A1 (de) * | 2001-12-13 | 2003-07-03 | Aventis Pharma Gmbh | Verfahren zur Bestimmung der Aktivität der Ornithin-Decarboxylase sowie zur Identifizierung von Effektoren der Ornithin-Decarboxylase-Aktivität |
| WO2003059948A1 (en) * | 2002-01-15 | 2003-07-24 | Medigene Ag | Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes |
| ES2770067T3 (es) | 2004-05-11 | 2020-06-30 | Ncardia Ag | Descubrimiento de fármacos basado en células diferenciadas in vitro |
| US20070179815A1 (en) * | 2006-01-20 | 2007-08-02 | Heartscreen America, Inc. | Medical screening system and method |
| EP2046997A2 (en) * | 2006-07-25 | 2009-04-15 | Deutsches Krebsforschungszentrum | A common gene expression signature in dilated cardiomyopathy |
| EP2347265A1 (en) * | 2008-10-17 | 2011-07-27 | Roche Diagnostics GmbH | Use of biglycan in the assessment of heart failure |
| EP2912458B1 (en) | 2012-10-24 | 2018-07-18 | NYU Winthrop Hospital | Non-invasive biomarker to identify subjects at risk of preterm delivery |
| KR20200109293A (ko) | 2017-09-13 | 2020-09-22 | 프로제너티, 인크. | 자간전증 바이오마커 및 관련된 시스템 및 방법 |
| WO2021113710A1 (en) | 2019-12-04 | 2021-06-10 | Progenity, Inc. | Assessment of preeclampsia using assays for free and dissociated placental growth factor |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0755446T3 (da) * | 1994-04-25 | 2007-01-29 | Genentech Inc | Cardiotrophin og anvendelser deraf |
| US5972693A (en) | 1995-10-24 | 1999-10-26 | Curagen Corporation | Apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing |
-
1998
- 1998-11-09 US US09/189,618 patent/US6610480B1/en not_active Expired - Fee Related
- 1998-11-10 WO PCT/US1998/023953 patent/WO1999024571A2/en not_active Ceased
- 1998-11-10 AU AU13953/99A patent/AU1395399A/en not_active Abandoned
- 1998-11-10 JP JP2000520565A patent/JP2002508923A/ja active Pending
- 1998-11-10 EP EP98957774A patent/EP1030916A2/en not_active Withdrawn
- 1998-11-10 CA CA002309360A patent/CA2309360A1/en not_active Abandoned
-
2006
- 2006-11-30 JP JP2006323823A patent/JP2007135219A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999024571A3 (en) | 1999-08-26 |
| WO1999024571A2 (en) | 1999-05-20 |
| US6610480B1 (en) | 2003-08-26 |
| EP1030916A2 (en) | 2000-08-30 |
| JP2007135219A (ja) | 2007-05-31 |
| JP2002508923A (ja) | 2002-03-26 |
| CA2309360A1 (en) | 1999-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6486299B1 (en) | Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity | |
| US6610480B1 (en) | Treatment and diagnosis of cardiac hypertrophy | |
| AU5575999A (en) | Leptin-related peptides | |
| CA2301862A1 (en) | Atrial natriuretic factor mutants and ischemic stroke | |
| EP1124572B1 (en) | Genes and proteins predictive and therapeutic for renal disease and associated disorders | |
| US20040167066A1 (en) | Cleavage and polyadenylation complex of precursor mrna | |
| US6875567B1 (en) | Method of detecting cardiac hypertrophy through probe hybridization and gene expression analysis | |
| US20020164735A1 (en) | Methods and compositions relating to a cardiac-specific nuclear regulatory factor | |
| CA2496891A1 (en) | Novel actin-related cytoskeletal protein lacs | |
| Germain-Lee et al. | NVL: a new member of the AAA family of ATPases localized to the nucleus | |
| AU2003203787B2 (en) | Differentially Expressed Genes in Cardiac Hypertrophy and their uses in Treatment and Diagnosis | |
| WO2008110356A2 (en) | Protein pi 16 secreted from the heart and uses thereof | |
| WO1999033987A1 (en) | Cloning of a high growth gene | |
| AU2006225276A1 (en) | Differentially Expressed Genes in Cardiac Hypertrophy and their uses in Treatment and Diagnosis | |
| AU2004223739A1 (en) | Cyclic AMP response element activator proteins and uses related thereto | |
| US20040241807A1 (en) | Interleukin-1 related gene and protein | |
| EP1406665A2 (en) | Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis | |
| EP1345962A2 (en) | Methods and compositions relating to cardiac-specific nuclear regulatory factors | |
| JP3629759B2 (ja) | プロテアソームアクチベーター | |
| US20060264610A1 (en) | Protein complexes of the tip60 transcriptional activator protein | |
| JPWO2002064770A1 (ja) | 新規スカベンジャー受容体クラスa蛋白質 | |
| WO1997043415A1 (en) | Cyclin d binding factor, and uses thereof | |
| Stuermer | Analysis of the reticulon gene family demonstrates the absence of the neurite growth inhibitor Nogo-A in fish | |
| AU2002249874A1 (en) | Methods and compositions relating to a cardiac-specific nuclear regulatory factors | |
| WO2002046420A2 (en) | Nebulin-related protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |